Personal Care Chemicals-India
Personal Care Chemicals-India
Personal Care Chemicals-India
Chemicals
Quarterly Newsletter
May 2023
Table of Contents
Executive summary 3
Recent news 18
Recent transactions 19
With a growing focus towards health and well-being, Personal care chemicals are chemicals added to
the global personal care market has experienced a personal care products to enhance the efficacy, safety,
2.7% growth between CY15 and CY19, which remained shelf-life, and sensory experience of the products.
stagnant during the pandemic period. This is expected ~70% of these chemicals are commodity while 30% are
to grow at 4.7% in the forecast period between CY21 specialty chemicals.
and CY26. Enhanced accessibility to personal care
products through e-tail stores, and the globalization
of leading personal care brands (like L'Oréal, Clinique)
also contributed to the buoyancy of the personal care
industry.
The personal care chemicals are divided based on their application into the following categories:
Moisturizers, humectants,
Maintain healthy skin, address blemishes, dark spots, and
Skincare emollients, antioxidants, and
counter aging
sunscreens
Color Add color and texture to makeup products and are used in
Pigments, fillers, and binders
Cosmetics lipsticks, eyeshadows, and blushes
Based on their functionality, personal care chemicals are further classified as active and inactive:
/ Active ingredients are used in personal care and / Inactive ingredients provide physical and processable
cosmetic products to enhance their functional properties to a formulation as opposed to active
properties. They are used for purposes like properties. They are added for three major purposes:
anti-aging, exfoliation, sun protection, moisturizing, ― As a vehicle to deliver active ingredients to the
antimicrobial, skin lightening, and are used in skin skin
care products like facial and body creams, lotions,
― As a preservative to help maintain reasonable
masks, and other formulations
shelf life of the product
― To improve fine odor and appearance
65%
Source: 1. Indicative share based on CY19 numbers from Frost & Sullivan report
The personal care chemicals value chain commences either in-house or through third-party distributors.
with a basic chemical supplier, who provides base FMCG companies utilize these chemicals to create the
chemicals such as petrochemicals, solvents, and fatty final products such as shampoos and soaps, which are
acids to ingredient manufacturers. The ingredient distributed via the B2B or B2C approach. The personal
manufacturers process, synthesize, and purify the care value chain is a complex system with multiple
materials to produce personal care chemicals, which processes and players, each contributing their unique
are then distributed to global FMCG manufacturers, expertise and services to enable the creation and
distribution of high-quality personal care products.
FMCG manufacturer
Haircare products Cosmetic products Nail Care products Oral Care products
B2B/B2C
Include salons, retail stores, direct consumer, pharmacies, and department stores
Characteristics
Highly regulated
Personal care chemicals manufacturers must abide Globalized industry
by strict regulatory requirements in all countries Leading personal care brands have diversified
of operations. This is to ensure that their products manufacturing operations across the globe driven
are certified safe by meeting the regulatory by factors such as cost savings, operational
requirements governing labeling, packaging, efficiencies, and geographic expansion. This
and quality. Failure to comply with regulatory has resulted in a wider distribution of personal
requirements can result in fines, product recalls, care products, making them easily accessible to
and damage the company's reputation. consumers across regions. Hence, companies
have emerged across the globe to cater to the
requirements of personal care brands in a quicker
and more efficient way.
Constant innovation
The personal care industry is highly competitive,
with new product launches and innovations
happening frequently. To keep up with the ever-
changing consumer demands and stay ahead of the
competition, continuous and significant investments
in R&D are a must.
The market witnessed different growth prospects restrictions imposed due to COVID-19, before
between CY20 and CY22, depending on the sub- witnessing recovery in CY21-22. In contrast,
segments. For instance, in CY20, the demand for the demand for soaps, shampoos, and hand
ingredients such as cosmetics ingredients, hair sanitizers surged, which in turn increased
fixative polymers, and UV-protection ingredients demand for preservatives, surfactants,
declined. This was because of lower demand emollients, and conditioning polymers.
for color cosmetics, hair styling products, and
sun protection products owing to lockdown
Global personal care chemicals market size (USD bn) Indicative market share by geography (%)
CAGR:4.9% 7%
24%
CAGR:4.0% 14.6
35%
11.5
9.4
34%
Global personal care market (USD bn) Further, the global personal care industry is undergoing
a transformation due to the emergence of e-commerce,
which has disrupted traditional distribution channels
CAGR
and created new opportunities for industry players.
4.7%
This has led to the availability of a vast range of
products at competitive prices. The e-commerce
platforms have facilitated the entry of smaller and niche
personal care chemicals companies into new markets,
USD 571bn
USD 453bn enabling them to reach a wider customer base beyond
their traditional geographic boundaries.
CY21 CY26
Personal care chemicals market in India grew from in turn prompted personal care chemicals players to
USD 1.1 bn in FY20 to USD 1.6 bn in FY22 at a CAGR adjust their own prices. The market is expected to grow
of 20%, fuelled by strong demand from end-user at around 15% CAGR during FY22-27 and be come a
industries and also partly due to the increasing raw USD 3.2 bn market in FY27.
material prices owing to supply chain disruptions which
India personal care chemicals market size (USD bn) India personal care chemicals market by
nature of ingredients
15.0%
CAGR
20.5%
CAGR
1.8 39% 61%
1.0
1.4
0.7
0.6
0.4 Active ingredients Inactive ingredients
FY20 FY22 FY27
Active ingredients made up approximately 39% of
Active Ingredients Inactive Ingredients
the personal care chemicals market in India and are
likely to command a higher share going forward, with
consumers becoming more knowledgeable about
the ingredients used in personal care products, and
increasing demand for premium products. In India,
there is a discernible trend of consumers opting for
higher-end, luxury products that incorporate more
valuable active ingredients, which is driving growth.
This growth is being further propelled by various
factors, such as rising disposable incomes, growing
young workforce, and the expansion of organized retail.
Antimicrobials 33
Conditioning
57
Polymers
Emollients 39
Surfactants 35
UV Protection
56
Ingredients
The personal care chemicals market in India is characterized by a healthy competition between diversified
chemicals MNCs such as BASF, Croda, Clariant, etc. and niche domestic players such as Galaxy Surfactants,
Kumar Organics, etc.
Skin-brightening agents,
Anionic surfactants, and 6,3011 3.0% 20.9% 34.1%
Botanicals
Antibacterial ingredients,
Emollients, Skin-lightening
4,269 12.6% 13.7% 27.3%
ingredients, and Preservative
ingredients
Sunscreen chemicals,
preservatives, and salicylic acid 2,651 22.4% 10.2% 20.5%
& para-hydroxy benzoic acid
Anti-aging ingredients,
Antioxidants, and Sun 1,1003 29.6% 31.3% 46.4%
protection agents
Natural Synthetic
/ Highly competitive market with changing / Margin squeeze due to cost pressures
consumer preferences Personal care chemicals manufacturers rely on
Consumer preferences and expectations are many petrochemical sources as their raw materials.
undergoing constant transformation, evolving at an For instance, mineral oils are used in personal care
unprecedented pace. To remain in sync with these products such as lotions, creams, and lip balms.
developments, product manufacturers reformulate
Therefore, the margins are sandwiched between
a significant proportion of their products (typically
the price locked by a highly competitive market and
25-30% of their portfolio) and introduce nearly 80
the costs driven by commodity prices, logistics,
new active ingredients every year. Keeping pace
and conversion. Hence, cost pressures are a major
with this accelerated rate of change is crucial for
challenge to players in the personal care chemicals
manufacturers to retain their competitive edge in the
market.
fragmented market.
In essence, this implies that a manufacturer must
develop a diverse range of formulations to effectively
cater to the varied individual needs of customers
worldwide.
Feb-23 Ciech Group (49% stake) Poland Diversified Kulczyk 312 5.9x
Investments
Feb-23 Fuso Chemical (6% stake) Japan Lifescience & Electronic Kunpusha 58 5.7x
Chemicals
Feb-23 Thai Central Chemical (17% Thailand Agrochemicals Sojitz 115 14.4x
stake)
Feb-23 Solus Biotech South Korea Personal Care & Pharma Croda 279 NA
Jan-23 Lotte Chemical Pakistan Pakistan Commodity Chemicals Lucky Core 156 4.1x
(75% Stake) Industries
350
300
274.9
250
204.4
200
202.2
150
100
50
0
Nov-21
Mar-20
May-20
Jul-20
Sep-20
Nov-20
Jan-21
Mar-21
May-21
Jul-21
Sep-21
Jan-22
Mar-22
May-22
Jul-22
Sep-22
Nov-22
Jan-23
Mar-23
Company Name Segment M.Cap LTM LTM 3 Yr. 3 Yr. NTM EV/ NTM PE
(INR bn) Revenue EBITDA Sales Avg. EBITDA
(INR bn) (%) CAGR RoCE
Diversified
18.7x 30.1x
SRF Specialty 713 146 24.6% 20.5% 17.4%
18.6x 30.7x
Chemicals
6.9x 10.0x
UPL Agrochemicals 538 529 20.5% 28.4% 13.2%
7.7x 12.0x
24.3x 33.3x
PI Industries Agrochemicals 459 63 23.5% 23.1% 21.6%
29.2x 42.0x
Diversified
Navin Fluorine 31.3x 45.6x
Specialty 211 18 24.1% 13.4% 21.8%
International 36.0x 51.2x
Chemicals
Diversified
19.4x 29.9x
Atul Specialty 205 56 16.2% 8.0% 21.2%
20.6x 31.2x
Chemicals
Diversified
17.0x 29.4x
Aarti Industries Specialty 188 73 17.8% 18.9% 16.4%
20.6x 34.6x
Chemicals
Diversified
25.8x 30.9x
Vinati Organics Specialty 186 21 28.0% 12.7% 24.7%
31.6x 38.7x
Chemicals
Diversified
Clean Science and 27.9x 39.3x
Specialty 135 9 41.0% 20.3% 80.1%
Technology 48.1x 64.9x
Chemicals
Company Name Segment M.Cap LTM LTM 3 Yr. 3 Yr. NTM EV/ NTM PE
(INR bn) Revenue EBITDA Sales Avg. EBITDA
(INR bn) (%) CAGR RoCE
Diversified
10.5x 17.4x
BASF India Specialty 99 138 5.5% 29.5% 23.8%
16.2x 38.9x
Chemicals
7.4x 11.9x
Balaji Amines Life Sciences 63 27 26.9% 34.9% 31.9%
15.5x 23.5x
5.1x 11.1x
Sharda Cropchem Agrochemicals 44 40 19.5% 21.5% 20.0%
5.6x 12.3x
17.1x 23.7x
Bharat Rasayan1 Agrochemicals 38 14 16.6% 9.5% 31.5%
19.1x 28.0x
10.5x 17.9x
Rallis India Agrochemicals 38 30 7.4% 9.5% 14.9%
13.2x 21.3x
8.8x 11.6x
Dhanuka Agritech Agrochemicals 28 16 15.8% 13.7% 27.0%
12.2x 16.3x
Other
Advanced Enzyme 14.2x 24.7x
Specialty 26 5 28.1% 7.8% 21.2%
Technologies 14.2x 23.9x
Chemicals
This document is being furnished to you by Avendus Capital Private Limited for itself and its affiliates strictly on a
confidential basis. The document is for informational purposes only and should not be regarded as an offer to sell, or offer
for subscription, or as a solicitation of an offer to buy the securities or other investments mentioned in it. This information
profile has been provided to its recipient upon the express understanding that the information contained herein, or made
available in connection with any further investigation, is strictly confidential and is intended for the exclusive use of its
recipient. It shall not be photocopied, reproduced and/or distributed to others at any time without prior written consent.
Spark Institutional Equities Private Limited, SEBI registered broker-dealer & Research Analyst, is an affiliate of ACPL and
is engaged with ACPL on a non-exclusive business partnership for public market business. Any reference to “research”,
“research report” or other research related terms in this document refers to research capability and research team of one of
our partners and any engagement with such research team shall be subject to terms and conditions agreed between ACPL
and its partner.
All third-party logos / icons referenced by the Company remain the property of their respective owners solely. Any such
reference herein by the Company is only to identify the relevant entity / organisation and shall be considered honest and fair
use under the IP laws.
This document is neither a prospectus nor an invitation to subscribe to securities or other investments. Nothing in this
document is intended to constitute legal, tax, securities or investment advice, or opinion regarding the appropriateness
of any investment, or a solicitation for any product or service. The information herein is subject to change without notice.
Avendus Capital Private Limited does not represent that any information, including any third party information, is accurate or
complete and it should not be relied upon without proper investigation on the part of the investor/s.
Neither Avendus Capital Private Limited nor its affiliates nor any of its officers or employees accept any liability whatsoever
for any direct or consequential loss arising from any use of this publication or its contents. The recipient of the material
should rely on their own investigations and take their own professional advice. While we endeavor to update on a reasonable
basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from
doing so.
Investments in securities/equity related instruments are subject to market risk. These risks could be security specific or
market specific and arising from company, industry, political, economic (both domestic and global), etc, factors. Investor/s
should carefully read all disclosure documents before investing and shall not make Avendus Capital Private Limited and/or
its associates/employees liable for any risks/losses pertaining to any product/scheme offered by them from time to time.
Past performance does not indicate the future performance of any current or future fund or strategies advised or managed
by Avendus Capital Private Limited or its affiliates.
Distribution of this document in some jurisdictions may be restricted or prohibited by law and regulation, and accordingly
recipients of this document represent that they are able to receive it without contravention of any unfulfilled registration
requirements or any other legal or regulatory restrictions. Recipients of this document in such jurisdiction should fully inform
themselves about and observe all applicable legal or regulatory requirements and Avendus Capital Private Limited and its
affiliates, directors, shareholders, managers, officers, employees, agents and advisors, do not accept any liability to any
person in relation thereto.
For the purposes of distribution within the United Kingdom, this communication is exempt from the financial promotion
restriction in Section 21 of the Financial Services and Markets Act, 2000 relating to the communication of an invitation
or inducement to engage in investment activity on the grounds that it is made to those persons falling within the following
Articles of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended: Article 19
(Investment Professionals) and Article 49 (High Net Worth Companies). Any investment to which this communication relates
is only available to investment professionals and high net worth companies.
If you have received this document and you are not the person for whom it is intended, you should not rely on this
communication or act on it.
Avendus Capital Private Limited: CIN: U99999MH1999PTC123358 I SEBI Registration no.: Merchant Banking – INM000011021 I
Avendus Wealth Management Private Limited: CIN: U67120MH2008PTC179931 I SEBI Registered Portfolio Manager– INP000003625
I SEBI Registered Investment Advisor - INA000006527| Manager to SEBI Registered Category III Alternative Investment Fund (“AIF”)
– Avendus Equity Opportunities Fund - IN/ AIF1/17-18/0360| SEC – USA Registered Investment Advisor: URD no.: 156771 I Avendus
Capital , Inc: US SEC/ FINRA Registered broker-dealer and a State registered Investment Adviser - FINRA CRD #150160 and SEC #
8-68226 I Avezo Advisors Pvt. Ltd.: CIN: U74120MH2014PTC255373 I Manager to SEBI Registered Category I AIF - IN/AIF1/14-
15/0126 & IN/AIF3/15-16/0188 I Avendus Finance Private Limited: CIN: U65921MH1996PTC251407 | RBI Registered Non-banking
Financial Company – N-13.02080 I SEBI Registered depository participant (CDSL & NSDL) - IN-DP-375-2018 I Avendus PE Investment
Advisors Private Limited: CIN: U65990MH2009PTC191437 I Manager to SEBI registered Category II AIF – Avendus Structured Credit
I Investment Trust - IN/AIF2/17-18/0341 I Avendus Capital Public Markets Alternate Strategies LLP: LLP ID no.- AAI-3806 I Manager
to SEBI Registered Category III AIF – Avendus Alternate India Fund - IN/AIF3/16-17/0304 I SEBI Registered Portfolio Manager -
INP000006217 I Ocean Dial Asset Management India Private Limited: CIN: U74900MH2015PTC269770 I Manager to SEBI registered
Category III AIF – Ocean Dial Systematic Equity Fund - IN/AIF3/16-17/0284 I SEBI Registered Portfolio Manager - INP000006174 I
Ocean Dial Asset Management Limited, UK: Financial Conduct Authority, UK (FCA) Registered Investment Manager - 447424 | Avendus
Capital Pte Ltd.: Monetary Authority of Singapore Registered Fund Manager – CMS No. CMS100983 | Spark Institutional Equities Private
Limited: CIN: U65999TN2022PTC149473 I SEBI Registered Stock Broker (NSE & BSE) - INZ000307037 I SEBI Registered Research
Analyst – INH200009722